Skip to main content

Idursulfase Disease Interactions

There is 1 disease interaction with idursulfase.

Major

Idursulfase (applies to idursulfase) cardiac/pulmonary impairment

Major Potential Hazard, Moderate plausibility. Applicable conditions: Heart Disease, Fever, Fluid Retention

Patients with compromised respiratory function or acute respiratory disease may be at risk of serious acute exacerbation of their respiratory compromise due to hypersensitivity reactions during idursulfase therapy and require additional monitoring. Patients with compromised respiratory function or acute febrile or respiratory illness at the time of idursulfase infusion may be at higher risk of life-threatening complications from hypersensitivity reactions. Careful consideration should be given to the patient's clinical status before idursulfase administration and delaying the idursulfase infusion should be considered.

Caution is recommended when administering idursulfase to patients susceptible to fluid overload, or patients with acute underlying respiratory illness or compromised cardiac and/or respiratory function for whom fluid restriction is indicated; these patients may be at risk of serious exacerbation of their cardiac or respiratory status during infusions. Appropriate medical support and monitoring measures should be readily available during idursulfase infusion, and some patients may require prolonged observation times that should be based on the needs of each patient.

References

  1. (2018) "Product Information. Elaprase (idursulfase)." Shire US Inc, SUPPL-197

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.